Indian drugmakers deepen US market focus despite export decline in FY26, driven by pricing pressure, generics slowdown, and shift toward specialty drugs and local manufacturing.
Hidden thyroid risk in young India crosses 50%, study finds. Experts flag subclinical thyroid disorders, delayed diagnosis, and rising need for preventive screening.
India emerges as Novo Nordisk’s global launch engine, powering AI-led drug development, faster approvals, and stronger Wegovy data amid rising competition in obesity drugs.
A rare 1-in-9M brain disorder was diagnosed in a pregnant woman after migraine misdiagnosis, highlighting timely neurosurgery and expert care.
India has stepped up its global health response after the World Health Organization (WHO) declared an Ebola emergency, with India sending Ebola aid to Africa following the WHO health alert to support countries struggling with a growing outbrea...
Indian pharma is being hit by Gulf tensions and South Asia trade curbs, as rising geopolitical uncertainty and regional market restrictions begin to affect the smooth flow of medicines and raw materials. The sector, known globally for supplyin...
Immuneel Therapeutics CAR T therapy shows two-year remission in aggressive blood cancer, highlighting durable clinical outcomes and improved access to advanced cell therapy in India.
AstraZeneca’s experimental breast cancer pill, camizestrant has received a regulatory boost in Europe, despite its trial design facing US regulatory pushback.
Venus Remedies has strengthened its footprint in the Gulf region after receiving Marketing Authorization from the Saudi Food and Drug Authority for Plerixafor, a specialty injectable used in stem cell transplantation procedures.
India's e-pharmacy market is rapidly evolving with top apps offering hyperlocal delivery, AI-powered chronic care, and subscription models, even as the sector awaits a long-overdue regulatory framework.